Scientists Unlock How Cells Filter Faulty Mitochondrial DNA at Birth

Mitochondria are the cell's power generators, but they carry their own genome — mitochondrial DNA (mtDNA) — which mutates roughly 15 times faster than nuclear DNA. This rapid mutation rate poses a fundamental biological challenge: how does life maintain the cooperation between two genomes when one is so error-prone? The answer appears to involve a sophisticated quality-control system that has remained poorly understood until now.

Researchers from the University of Cambridge, working with mouse models and cell culture, identified Ubiquitin-specific peptidase 30 (USP30) as a critical regulator of mitochondrial quality during the maternal-to-zygotic transition — the earliest stages of embryonic life. During this window, purifying selection actively eliminates mitochondria carrying harmful mtDNA mutations, and USP30 modulates the intensity of this process.

When USP30 was inhibited, ubiquitin-mediated mitophagy — the cellular process of tagging and destroying damaged mitochondria — increased substantially. This enhanced clearance reduced the proportion of mutant mtDNA in affected cells. The findings suggest that USP30 normally acts as a brake on mitophagy, and releasing that brake can restore quality control.

A particularly important discovery was that high heteroplasmy (a high burden of mutant mtDNA) itself impairs the ubiquitin-proteasome system, creating a vicious cycle where heavily mutated cells lose the very machinery needed to clear defective mitochondria. This mechanism may explain why some mtDNA mutations escape quality control and accumulate enough to cause disease.

The therapeutic implication is significant: USP30 inhibitors could potentially reduce mutant mtDNA inheritance in at-risk pregnancies or treat established mitochondrial disease. While this work is currently in animal and in vitro models, it provides a compelling mechanistic rationale for developing USP30 as a drug target.